Atlas Trials

Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure

Clinical trial NCT03326843 · TERMINATED

Trial details

NCT number
NCT03326843
Sponsor
Sobi, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Thrombocytopenia
Start date
2018-03-26
Primary completion
2019-02-25
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.